These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8702726)
1. Molecular basis of canine muscle type phosphofructokinase deficiency. Smith BF; Stedman H; Rajpurohit Y; Henthorn PS; Wolfe JH; Patterson DF; Giger U J Biol Chem; 1996 Aug; 271(33):20070-4. PubMed ID: 8702726 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the enzymatic lesion in inherited phosphofructokinase deficiency in the dog: an animal analogue of human glycogen storage disease type VII. Vora S; Giger U; Turchen S; Harvey JW Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8109-13. PubMed ID: 2933748 [TBL] [Abstract][Full Text] [Related]
3. Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions. Nichols RC; Rudolphi O; Ek B; Exelbert R; Plotz PH; Raben N Am J Hum Genet; 1996 Jul; 59(1):59-65. PubMed ID: 8659544 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency. Vora S; Davidson M; Seaman C; Miranda AF; Noble NA; Tanaka KR; Frenkel EP; Dimauro S J Clin Invest; 1983 Dec; 72(6):1995-2006. PubMed ID: 6227635 [TBL] [Abstract][Full Text] [Related]
5. Haemolytic anaemia and exercise intolerance due to phosphofructokinase deficiency in related springer spaniels. Skibild E; Dahlgaard K; Rajpurohit Y; Smith BF; Giger U J Small Anim Pract; 2001 Jun; 42(6):298-300. PubMed ID: 11440399 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII. Vora S; DiMauro S; Spear D; Harker D; Danon MJ J Clin Invest; 1987 Nov; 80(5):1479-85. PubMed ID: 2960695 [TBL] [Abstract][Full Text] [Related]
15. A genetic defect in muscle phosphofructokinase deficiency, a typical clinical entity presenting myogenic hyperuricemia. Nakajima H; Kono N; Yamasaki T; Hotta K; Kawachi M; Hamaguchi T; Nishimura T; Mineo I; Kuwajima M; Noguchi T Adv Exp Med Biol; 1991; 309B():141-4. PubMed ID: 1838230 [No Abstract] [Full Text] [Related]
16. Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Raben N; Exelbert R; Spiegel R; Sherman JB; Nakajima H; Plotz P; Heinisch J Am J Hum Genet; 1995 Jan; 56(1):131-41. PubMed ID: 7825568 [TBL] [Abstract][Full Text] [Related]
17. Postnatal hematologic development in phosphofructokinase-deficient dogs. Harvey JW; Reddy GR Blood; 1989 Nov; 74(7):2556-61. PubMed ID: 2529931 [TBL] [Abstract][Full Text] [Related]
18. Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation. Sivakumar K; Vasconcelos O; Goldfarb L; Dalakas MC Neurology; 1996 May; 46(5):1337-42. PubMed ID: 8628478 [TBL] [Abstract][Full Text] [Related]
19. Muscle phosphofructokinase deficiency in two generations. Vorgerd M; Karitzky J; Ristow M; Van Schaftingen E; Tegenthoff M; Jerusalem F; Malin JP J Neurol Sci; 1996 Sep; 141(1-2):95-9. PubMed ID: 8880699 [TBL] [Abstract][Full Text] [Related]